| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $16.6B | $15.1B | $14.3B | $15.1B | $14.9B | $13.9B | $8.7B | $8.3B |
| Cost of Revenue | $18.2B | $16.9B | $20.4B | $17.4B | $17.4B | $15.4B | $7.4B | $7.7B |
| Gross Profit | $12.1B | $10.7B | $8.6B | $11.0B | $10.6B | $9.2B | $6.7B | $6.3B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $14.0B | $14.8B | $12.9B | $15.3B | $12.3B | $11.3B | $6.9B | $7.4B |
| Operating Income | $15.1B | $9.1B | $12.8B | $18.1B | $17.9B | $11.4B | $13.0B | $6.4B |
| Net Income | $1.8B | $-0.0B | $0.8B | $2.5B | $4.0B | $0.0B | $2.8B | $-1.8B |
| EPS (Basic) | $1.02 | $-0.02 | $0.46 | $1.39 | $2.27 | $0.01 | $1.88 | $-1.23 |
| EPS (Diluted) | $1.02 | $-0.02 | $0.46 | $1.38 | $2.26 | $0.01 | $1.88 | $-1.23 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $134.0B | $135.2B | $134.7B | $138.8B | $146.5B | $150.6B | $89.1B | $59.4B |
| Current Assets | $29.1B | $25.6B | $33.0B | $28.5B | $27.9B | $24.2B | $49.5B | $16.9B |
| Cash & Equivalents | $5.2B | $5.5B | $12.8B | $9.2B | $9.7B | $8.4B | $39.9B | $7.3B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $43.3B | $38.7B | $37.8B | $29.5B | $35.2B | $28.7B | $15.6B | $17.2B |
| Stockholders' Equity | $-3.3B | $3.3B | $10.4B | $17.3B | $15.4B | $13.1B | $-8.2B | $-8.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $19.0B | $18.8B | $22.8B | $24.9B | $22.8B | $17.6B | $13.3B | — |
| Investing Cash Flow | $-6.6B | $-20.8B | $-2.0B | $-0.6B | $-2.3B | $-37.6B | $0.6B | — |
| Capital Expenditures | $1.2B | $1.0B | $0.8B | $0.7B | $0.8B | $0.8B | $0.6B | $0.6B |
| Financing Cash Flow | $-12.7B | $-5.2B | $-17.2B | $-24.8B | $-19.0B | $-11.5B | $18.7B | $-14.4B |